-
Loading metrics
Open Access
Peer-reviewed
Research Article
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer
-
Ryotaro Ohkuma,
Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing
Affiliations Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan, Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan, Department of Physiology, Graduate School of Medicine, Showa University, Tokyo, Japan
⨯ -
Erica Yada,
Roles Data curation, Formal analysis, Investigation, Methodology
Affiliation Kanagawa Cancer Center Research Institute, Kanagawa, Japan
⨯ -
Shumpei Ishikawa,
Roles Data curation, Formal analysis, Methodology
Affiliation Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
⨯ -
Daisuke Komura,
Roles Data curation, Formal analysis, Methodology
Affiliation Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
⨯ - Hidenobu Ishizaki,
-
Koji Tamada,
Roles Investigation, Project administration
Affiliation Department of Immunology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan
⨯ -
Yutaro Kubota,
Roles Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Kazuyuki Hamada,
Roles Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Hiroo Ishida,
Roles Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Yuya Hirasawa,
Roles Formal analysis, Investigation, Methodology, Resources
Affiliations Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan, Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ -
Hirotsugu Ariizumi,
Roles Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Etsuko Satoh,
Roles Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Midori Shida,
Roles Formal analysis, Methodology
Affiliations Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ -
Makoto Watanabe,
Roles Formal analysis, Methodology
Affiliations Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ -
Rie Onoue,
Roles Formal analysis, Methodology
Affiliations Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ -
Kiyohiro Ando,
Roles Data curation, Formal analysis, Methodology
Affiliations Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ -
Junji Tsurutani,
Roles Formal analysis, Methodology
Affiliations Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan, Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan
⨯ -
Kiyoshi Yoshimura,
Roles Formal analysis, Methodology
Affiliations Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan, Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ -
Takehiko Yokobori,
Roles Formal analysis, Validation
Affiliation Department of Innovative Immune-Oncology Therapeutics, Graduate School of Medicine, Gunma University, Gunma, Japan
⨯ -
Tetsuro Sasada,
Roles Data curation, Formal analysis, Investigation, Methodology
Affiliation Kanagawa Cancer Center Research Institute, Kanagawa, Japan
⨯ -
Takeshi Aoki,
Roles Investigation, Resources
Affiliation Department of Surgery, Division of General and Gastroenterological Surgery, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Masahiko Murakami,
Roles Investigation, Resources
Affiliation Department of Surgery, Division of General and Gastroenterological Surgery, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Tomoko Norose,
Roles Data curation, Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Pathology and Laboratory Medicine, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Nobuyuki Ohike,
Roles Data curation, Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Pathology and Laboratory Medicine, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Masafumi Takimoto,
Roles Data curation, Formal analysis, Investigation, Methodology, Resources
Affiliation Department of Pathology and Laboratory Medicine, School of Medicine, Showa University, Tokyo, Japan
⨯ -
Masahiko Izumizaki,
Roles Supervision
Affiliation Department of Physiology, Graduate School of Medicine, Showa University, Tokyo, Japan
⨯ -
Shinichi Kobayashi,
Roles Data curation, Formal analysis, Methodology
Affiliation Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ -
Takuya Tsunoda,
Roles Formal analysis, Investigation, Methodology, Resources, Supervision, Writing – review & editing
Affiliation Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan
⨯ - [ ... ],
-
Satoshi Wada
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – review & editing
* E-mail: st-wada@med.showa-u.ac.jp
Affiliations Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan, Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan, Clinical Research Institute for Clinical Pharmacology & Therapeutics, Showa University, Tokyo, Japan
⨯ - [ view all ]
- [ view less ]
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer
- Ryotaro Ohkuma,
- Erica Yada,
- Shumpei Ishikawa,
- Daisuke Komura,
- Hidenobu Ishizaki,
- Koji Tamada,
- Yutaro Kubota,
- Kazuyuki Hamada,
- Hiroo Ishida,
- Yuya Hirasawa
- Published: January 10, 2020
- https://doi.org/10.1371/journal.pone.0226707